Latest News & Features
Americas
South Korean firm has sued two manufacturers in Delaware alleging patent infringement | SKBP asked court to stop ANDAs from Aurobindo and Zenara until patents expire. 19 June 2024
Big Pharma
Judge says lower court abused discretion when issuing injunction | Negative impact of potential Medtronic deal on Insulet was “mere conjecture”. 18 June 2024
Big Pharma
New Jersey court grants 30-day stay days after ordering the removal of five patents for asthma inhalers from FDA Orange Book | Decision follows ruling favouring Amneal Pharmaceuticals, which argued the patents were improperly listed. 18 June 2024
Biotechnology
Biotech takes legal action against Tempus AI, alleging patent infringement in Tempus's liquid biopsy products | Complaint accuses Tempus of unauthorised use of Guardant's tech crucial for cancer diagnostics. 13 June 2024
Biotechnology
Finnish health tech firm says Ultrahuman’s motion to stay would significantly prejudice case | Oura claims Indian company trying to circumvent ITC exclusion order. 13 June 2024
Big Pharma
New counsel previously worked in-house at major pharmaceutical firm | Ex-Fenwick & West attorney has advised clients in areas including gene editing and antibodies. 13 June 2024
Big Pharma
Court grants temporary restraining order against defendants following Roche allegations | Company claims India-based counterfeiters selling low-quality diabetes test products on Amazon. 13 June 2024
Biotechnology
Illumina and Molecular Loop have filed complaints over DNA testing innovations | Illumina said one Molecular Loop patent was unenforceable due to ‘inequitable conduct’ 11 June 2024
Big Pharma
Victory for Amneal Pharmaceuticals as court dismisses infringement claims | Decision orders Teva to remove patents covering its breathing drug from the FDA's Orange Book | Paves the way for Amneal's generic version. 11 June 2024
Careers
Latest addition to the firm brings medtech expertise and experience assisting digital health companies using AI and machine learning | Move comes at a time when “health care companies are thinking more like technology companies”. 6 June 2024